A carregar...
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population
BACKGROUND: Although dual-boosted protease inhibitors regimen is not recommended in children with HIV infection, such a strategy could be useful in subjects with a complex resistance profile. This study was aimed at assessing the long term efficacy and safety of a double-boosted protease inhibitor c...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3434076/ https://ncbi.nlm.nih.gov/pubmed/22866946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-179 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|